After identifying the 17 strongest putative metabolites associated with T2D (Fig. 1), we examined whether these compounds may exert their effects by modulating IS (Matsuda ISI) or insulin secretion (DI30). This evidence concerns the gene INS and type 2 diabetes mellitus.